BMS to Build State-of-the-Art Campus in Lawrenceville, NJ
Bristol-Myers Squibb Company (BMS) has announced plans to build a 650,000-sq ft office building on company-owned land at the intersection of Princeton Pike and Interstate 295 in Lawrenceville, New Jersey. Construction is expected to begin this fall and the new facility is expected to open by the end of 2016.
The new facility is part of the company’s broader strategic plan to modernise its workspace to enable greater collaboration, increase technological capabilities and enhance productivity. The new facility will allow the company to consolidate operations currently located in leased office space at 777 Scudders Mill Road in Plainsboro Township and at Nassau Park Boulevard in West Windsor Township. The Princeton Pike location was purchased by BMS from RCN Corp. in 2001.
“We are proud to expand our presence in Lawrenceville, a community that has been home to our company for more than 40 years,” says CEO Lamberto Andreotti. “Our new campus will create a dynamic and modern workplace to advance the important work that our employees are doing to discover, develop and deliver innovative medicines for patients with serious diseases.”
The Lawrence Township Planning Board unanimously approved final site plans for the new campus in June. The new campus will be the company’s second in Lawrence Township, joining its worldwide headquarters at US Route 206 and Province Line Road, which opened in 1971. The company currently employs more than 2000 people at the Route 206 campus and more than 6000 in Central New Jersey. Once completed, as many as 2500 people will work at the new facility.
“I'm excited that BMS has decided to increase their investment in Lawrence Township,” says Lawrence Township Mayor Cathleen Lewis. “The company has been a constant partner in making Lawrence Township a great community; this new project will continue that legacy. We appreciate the confidence BMS has shown in our town and it is another sign that Lawrence is a great place for businesses to invest.”
The new facility represents the company’s broader strategic initiative to modernise its facilities through improved technology, more efficient design and workspace that enables collaboration, creativity and innovation. Employees will have state-of-the-art tools to collaborate and enhance their productivity, including personal desktop video capabilities and an immersive, high-definition video conferencing environment. The entire working environment will be both wired and wireless to enable employees to access the applications and information they need no matter where they are on the campus while using whatever computing device makes them most productive. BMS is introducing similar open work spaces around the world.
The new campus also is designed to be friendly to the environment and neighbors. The buildings are targeted to meet LEED certification standards for energy and environmental design. Most mechanical equipment will be located below ground to reduce noise. The site plans preserve the historic Brearley Oak tree located directly opposite Lenox Drive. A segment of the Lawrence Hopewell Trail on the campus will link to a network of walking paths on the property, and nearly half of the 134-acre tract will remain working farmland. There will be preferred parking areas for hybrid vehicles and indoor bicycle racks. The parking areas will be paved with porous pavement to reduce runoff and promote recharging of groundwater aquifers.
Related News
-
News Patients vs Pharma – who will the Inflation Reduction Act affect the most?
The Inflation Reduction Act brought in by the Biden administration in 2022 aims to give better and more equitable access to healthcare in the USA. However, pharma companies are now concerned about the other potential costs of such legislation. -
News CPHI Podcast Series: What does the changing US Pharma market mean for industry and patients alike?
In this week's episode of the CPHI Podcast Series Lucy Chard, Digital Editor for CPHI Online is joined by James Manser to discuss the political and market changes in the US pharma field. -
News CPHI Barcelona Annual Report illuminates industry trends for 2024
The CPHI Annual Survey comes into it’s 7th year to report on the predicted trends for 2024. Over 250 pharma executives were asked 35 questions, with their answers informing the industry landscape for the next year, spanning all major pharma marke... -
News Which 10 drugs are open to price negotiation with Medicare in the USA?
The Centres for Medicare & Medicaid Services, under the Biden administration in the USA, has released a list of the 10 drugs that will be open to price negotiations as part of the new legislation under the Inflation Reduction Act (IRA). -
News EU Medical Devices Regulation causes unintended disappearances of medical devices for children, doctors state
Doctor groups and associations have appealed to the EU to correct the EU Medical Devices Regulation law that may cause unintended shortages of essential drug and medical devices for children and rare disease patients. -
News 10 Major Drug Approvals So Far in 2023
Last year, 37 novel drugs were approved by the FDA, this was a high number for such a category, and covered many fields including oncology, demonstrating how promising further research is, and how it is only continuing to build. To date, there are alre... -
News Detecting Alzheimer's disease with a simple lateral flow test
A novel rapid diagnostic test for early-stage Alzheimer's disease has been developed using a biomarker binder from Aptamer Group along with technology from Neuro-Bio, the neurodegenerative disease experts. -
News CPHI Podcast Series: outsourcing and manufacturing trends
Listen to the CPHI Podcast Series this June to hear Gil Roth of the PBOA speak with Digital Editor Lucy Chard about the biggest trends and topics to watch in pharma outsourcing and manufacturing at the minute.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance